The prospects for a one-time treatment that reduces the risk of heart disease for the rest of a person’s life just got ...

Verve Therapeutics said Monday that initial data show that its investigational gene-editing therapy lowered cholesterol ...

Wall Street analysts said the results for Verve’s therapy appeared competitive on efficacy, while avoiding any major safety ...

The Boston-based company said its gene-editing treatment for people with high cholesterol was well-tolerated with no serious ...

CRISPR gene-editing technology offers curative potential for genetic diseases. The gene-editing market is projected to reach $30.8 billion by 2032. Top gene-editing pioneers include Intellia ...

Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...

Now, the self-styled gene editing pioneer is trying to stage a comeback with another controversial project, aiming to use gene editing to prevent Alzheimer’s disease in future generations.

Researchers in Israel have found a way to use revolutionary gene-editing technology to treat head and neck cancers. They say they can identify the single gene that fuels the growth of the cancer cells ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.